$2.63 0.02 (+0.77%)
11/6/2009 4:00 PM

EXACT Sciences Corp (EXAS)

CAPS Rating: 5 out of 5

An applied genomics company that develops proprietary DNA-based technologies for use in the detection of cancer.

Recs

3
Member Avatar wymichael (53.17) Submitted: 11/2/2007 7:28:03 PM : Outperform Start Price: $4.23 EXAS Score: -12.83

Let's see, would you prefer an invasive test for colon cancer, or a non-invasive one?

Report this Post 0 Comments

Featured Broker Partners